ClinicalTrials.govpublic full text
Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC Adenocarcinoma
nsclc, recurrent, adenocarcinoma of lung, nsclc, non-small cell lung cancer, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 889345
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.